Tim Mitchell's Email & Phone Number

💼 Past Experience

I saw (registered with FDA and other regulatory agencies) an initial manufacturing sample of an alpha1 protease inhibitor (Api) from their product brandI was responsible for all NPP and QC aspects of the manufacture of this product from a #1 global producer. I managed the process day-by-day, ensuring that all product quality requirements were met and that procedures were followed to minimize the risk of api quality issues. I also ensured that product and material purity was maintained, which contributed to the company's high reputation.They are a global player in beta-lactamase inhibitor manufacturingI saw the raw APi in finished product and resolved quality and product safety issues. We produced high quality Api products that met all customer requirements and customers generally loved them.

🎓 Education

Tim Mitchell's education hasprovided him with a strong background in biochemistry and genetics which has been essential in his current work readiness. Mitchell's education has also provided him with a strong foundation in how to think and problem-solve in scientific disciplines. Additionally, Mitchell's education has given him the ability to workatiably with other team members in order to accomplish tasks.

💡 Technical & Interpersonal Skills

Jason Kavanaugh is currently a Manufacturing Facility Engineer for Alpha-1 Protease Inhibitor Manufacturing at Palatin Biotechnology, LP from 2006 to 2010 (2 years). Jason developed, designed, and manages plant quality control processes and monitors Madison, Wisconsin-based Palatin Biotechnology as a partner in their cooperative research and development program with Hoffmann-La Roche. With PalatinBiotechnology, Jason has led the planning, design and execution of plant design, installation and operation. Jason has also taughtvisory training programs in quality assurance and quality control for advanced cellular technology companies.Product Manager - Scitabolin, Inc. (Clinical Development) from 2006 to 2009 (3 years), also Principal Investigator,(Clinical Development) of a Phase III clinical study of scitabolin (a neoantidiabetic agent) to improve glycemic control in type 2 diabetes mellitus. Jason was responsible for all aspects of the Drug Degradation and Elimination Studies (DDES) and Design and Sponsorship of the Clinical Trial. Jason also served as Project Manager, here at Scitabolin.Head of Manufacturing, Scitabolin, Inc. (Clinical Development) from 2006 to 2009 (3 years), also Principal Investigator,(Clinical Development) of a Phase III clinical study of scitabolin (a neoantidiabetic agent) to improve glycemic control in type 2 diabetes mellitus. Jason was responsible for all aspects of the Drug Degradation and Elimination Studies (DDES) and Design and Sponsorship of the Clinical Trial. Jason also served as Project Manager, here at Scitabolin. Vice President, Manufacturing - African American Diabetes Care (AADA) from 2004 to 2006 (4 years). With AADA, I led the development and implementation of all aspects of the company's manufacturing strategy, including human macromolecule production, PDRAM production, and product quality control. I also initiated and led a number of strategies for marketing and selling the company's products to patients.VP Manufacturing - African American Diabetes Care from 2004 to 2006 (4 years). With AADA, I led the development and implementation of all aspects of the company's manufacturing strategy, including human macromolecule production, PDRAM production, and product quality control. I also initiated and led a number of strategies for marketing and selling the company's products to patients. Vice President and Head of Product Development - human macromolecule production and Scitabolin, Inc. (Clinical Development) from 1999 to 2004 (5 years). With Scitabolin, I led product development including human macromolecule production, PDRAM production, and product quality control. I also initiated and led a number of strategies for marketing and selling the company's products to patients.Human Macromolecule Production - Scitabolin, Inc. (Clinical Development) from1999 to 2004 (5 years). With Scitabolin, I led product development including human macromolecule production, PDRAM production, and product quality control. I also initiated and led a number of strategies for marketing and selling the company's products to patients. Vice President